Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Trio-Tech International
(NY:
TRT
)
4.775
USD
-0.565 (-10.58%)
Streaming Delayed Price
Updated: 2:37 PM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
70,530
Open
5.170
Bid (Size)
4.750 (5)
Ask (Size)
4.800 (2)
Prev. Close
5.340
Today's Range
4.640 - 5.200
52wk Range
2.432 - 7.500
Shares Outstanding
3,553,055
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Trio-Tech Reports Second Quarter Net Income of $0.06 Per Diluted Share
February 11, 2021
Trio-Tech International (NYSE MKT: TRT) today announced financial results for the second quarter and first six months of fiscal 2021.
From
Business Wire News Releases
Trio-Tech Reports First Quarter Results
November 13, 2020
The net loss for 1Q fiscal 2021 was $8,000, or $0.00/share, compared to net income of $273,000, or $0.07/diluted share in the first quarter last year
From
Business Wire News Releases
Performance
YTD
+18.57%
+18.57%
1 Month
+1.17%
+1.17%
3 Month
+23.65%
+23.65%
6 Month
+29.93%
+29.93%
1 Year
+44.70%
+44.70%
More News
Read More
Trio-Tech Reports Fourth Quarter and Fiscal 2020 Results
September 23, 2020
From
Business Wire News Releases
Trio-Tech Reports Third Quarter Results
May 21, 2020
From
Business Wire News Releases
Aytu BioScience’s (NasdaqCM: AYTU), Natesto®, May Emerge As The Best-In-Class Testosterone Replacement (TRT) Drug – (Video Report)
April 23, 2019
Tags
Business
Pharmaceuticals & Biotech
Health & Medicine
From
AB Newswire
Is Aytu BioScience’s (NasdaqCM: AYTU) Natesto® About To Upend The Testosterone (TRT) Drug Market?
April 18, 2019
Tags
Health & Medicine
Pharmaceuticals & Biotech
Financial Market
From
AB Newswire
Insider Sells Trio-Tech International's Stock
January 19, 2021
Tags
BZI/IT
Markets
TRT
From
Benzinga
Trio-Tech Reports Second Quarter Net Income of $0.11 Per Diluted Share
February 13, 2020
From
Business Wire News Releases
Insider Sells Trio-Tech International's Stock
January 13, 2021
Tags
Benzinga
Insider Trades
News
From
Benzinga
Trio-Tech First Quarter Net Earnings Per Diluted Share Increased to $0.07 versus $0.02
November 13, 2019
From
Business Wire News Releases
Insider Sells Trio-Tech International's Shares
January 11, 2021
Tags
News
Benzinga
Insider Trades
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.